Connect
MJA
MJA

The resurgence of congenital syphilis in Australia: novel approaches and sustained, effective public health efforts are required

Stephanie Bond and Marcus Y Chen
Med J Aust 2024; 221 (4): 195-196. || doi: 10.5694/mja2.52393
Published online: 19 August 2024

In this issue of the MJA, Hengel and colleagues1 report that the syphilis rate among women of reproductive age is rising in Australia. Their analysis of national notifications data indicate that 5011 cases of infectious syphilis in women aged 15–44 years were notified during 2011–2021, the annual number increasing from 141 in 2011 to 902 in 2021. During the same period, 74 cases of congenital syphilis were notified: 40 in Aboriginal and Torres Strait Islander infants, 32 in non‐Indigenous infants, and two in infants of unknown Indigenous status. Seventeen of the infants were stillborn; the mothers of 41 infants with congenital syphilis resided in major cities, and 32 had not received antenatal care.1

Until recently, syphilis cases in Australia were highly concentrated among men who have sex with men and in remote Aboriginal and Torres Strait Islander communities. During the past decade, however, this has changed. The number of notifications among women living in urban areas has risen, leading to a worrying resurgence of congenital syphilis.2 Meanwhile, rates among Aboriginal and Torres Strait Islander people have continued to climb in several states and territories.1 Increased rates of congenital syphilis have also been reported in other high income countries, including the United States, where the number of cases increased by 755% during 2012–2022.3

The resurgence of congenital syphilis indicates a breakdown in syphilis control, and should be seen as an urgent call to action. In the past, syphilis outbreaks have occurred where there is socio‐economic disadvantage and health services are unable to provide adequate testing, treatment, and sexual partner management.4 Reversing the increase in congenital syphilis numbers is achievable only if syphilis control measures are sufficiently targeted and intense to reduce syphilis rates among women of reproductive age.

A recent Australian study found that syphilis is probably most transmissible during the second stage of infection, when asymptomatic shedding of Treponema pallidum from mucosal sites, including the mouth and saliva, peaks.5 To prevent T. pallidum dissemination and mucosal shedding, a paradigm shift in strategy is needed, to improve detection of primary and very early latent syphilis. This requires ready access to polymerase chain reaction (PCR) testing for T. pallidum in primary lesions, and frequent serological screening of people at particular risk of infection to detect very early asymptomatic syphilis.

If syphilis is detected in a woman early in pregnancy, congenital syphilis is almost certainly preventable.6 Infections during later pregnancy, including repeat infections from untreated sexual partners, increase the risk of mother‐to‐child transmission and the devastating consequences of congenital syphilis. Syphilis screening at the first antenatal visit is usual in Australia, but repeat screening during later pregnancy should also be routine. Australian pregnancy care guidelines recommend syphilis testing at the first antenatal contact, and repeat testing in the third trimester and at the time of birth for women at high risk of infection or re‐infection; in the case of a current local syphilis outbreak, testing at five timepoints during the course of the pregnancy and the birth and post partum periods is recommended.7 The many limitations of risk‐based screening include incomplete risk assessments of some women, time constraints in the clinic, and poor awareness of syphilis risk among both clinicians and the public. The American College of Obstetricians and Gynaecologists now advises universal re‐screening during the third trimester and at birth rather than a risk‐based approach to testing.8

Gaps in syphilis‐related care during pregnancy in Australia include insufficient testing, incorrect treatment, inadequate engagement with care as the pregnancy progresses, and not testing and treating the sexual partners of pregnant women.9 These problems are often exacerbated by factors such as housing instability, drug and alcohol use, and family violence. Babies at high risk of syphilis should also be followed up,9 and completion of treatment ensured when infection is confirmed.

Doing more of the same will not reverse the persistent rise in syphilis rates in Australia. The basic tools of syphilis control — testing and repeat testing, treatment, sexual partner management — need to be targeted effectively. This is particularly important for people and groups who are socio‐economically disadvantaged or marginalised. Effective control requires adequate funding and resources to support action across the health services used by people with syphilis, including general practices, sexual health clinics, Aboriginal and Torres Strait Islander health services, and antenatal services.

New methods of syphilis testing should be evaluated, including highly sensitive PCR testing; extending the use of multiplex PCR testing of oral, anal and genital ulcers to distinguish syphilis from herpes simplex infections, together with education about the available test options; universal repeat screening during later pregnancy; and introducing self‐testing and improving point‐of‐care‐testing, including assays that reliably distinguish current from past syphilis infections. Several clinical trials have found that post‐exposure prophylaxis with doxycycline can be effective in reducing the incidence of syphilis among people at risk of sexually transmitted diseases.10 This approach could be part of a broader strategy for controlling syphilis among people other than pregnant women, but there are some concerns, given the risk of antimicrobial resistance. Advances in genomic sequencing of T. pallidum open the prospect of real time tracking of syphilis epidemics and improved targeting of effective public health responses.11

Targeted efforts to reduce the stigma attached to sexual health testing and treatment would encourage people to seek care without fear of discrimination. Coordinated policies in both antenatal and sexual health care, clear guidelines, and broad education programs are needed to reduce the rate of congenital syphilis in Australia. Congenital syphilis has been eliminated in several countries in the Americas.12 This shows that novel approaches and sustained, effective public health efforts can control this devastating infection.

 


Provenance: Commissioned; externally peer reviewed.

  • Stephanie Bond1,2
  • Marcus Y Chen1

  • 1 Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC
  • 2 Sexual Health and Rapid Access Gynaecology, the Royal Women's Hospital, Melbourne, VIC


Correspondence: mchen@mshc.org.au

Competing interests:

No relevant disclosures.

  • 1. Hengel B, McManus H, Monaghan R, et al. Notification rates for syphilis in women of reproductive age and congenital syphilis in Australia, 2011–2021: a retrospective cohort analysis of national notifications data. Med J Aust 2024; 221: 201‐208.
  • 2. King J. McManus H, Kwon J, et al. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2023. Sydney: Kirby Institute; UNSW Sydney, 2023. https://www.kirby.unsw.edu.au/sites/default/files/documents/Annual‐Surveillance‐Report‐2023_HIV.pdf (viewed July 2024).
  • 3. Centers for Disease Control and Prevention. Vital signs: syphilis in babies reflects health system failures. Updated 14 Dec 2023. https://www.cdc.gov/vitalsigns/newborn‐syphilis/index.html (viewed July 2024).
  • 4. Park E, Yip J, Harville E, et al. Gaps in the congenital syphilis prevention cascade: qualitative findings from Kern County, California. BMC Infect Dis 2022; 22:129.
  • 5. Towns JM, Leslie DE, Denham I, et al. Treponema pallidum detection in lesion and non‐lesion sites in men who have sex with men with early syphilis: a prospective, cross‐sectional study. Lancet Infect Dis 2021; 21: 1324‐1331.
  • 6. Alexander JM, Sheffield JS, Sanchez PJ, et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 1999; 93: 5‐8.
  • 7. Australian Living Evidence Collaboration. Australian pregnancy care guidelines, version 3. Updated 21 June 2024. https://leappguidelines.org (viewed July 2024).
  • 8. American College of Obstetricians and Gynecologists. Screening for syphilis in pregnancy [practice advisory]. Apr 2024. https://www.acog.org/clinical/clinical‐guidance/practice‐advisory/articles/2024/04/screening‐for‐syphilis‐in‐pregnancy (viewed July 2024).
  • 9. Wu M, Seel M, Britton S et al. Addressing the crisis of congenital syphilis: key findings from an evaluation of the management of syphilis in pregnancy and the newborn in south‐East Queensland. Aust N Z J Obstet Gynaecol 2022; 62: 91‐97.
  • 10. Luetkemeyer AF, Donnell D, Dombrowski JC, et al; DoxyPEP Study Team. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med 2023; 388: 1296‐1306.
  • 11. Williamson DA, Chen M. Emerging and reemerging sexually transmitted infections. N Engl J Med 2020; 382: 2023‐2032.
  • 12. Pan American Health Organization. Epidemiological review of syphilis in the Americas. Dec 2021. https://iris.paho.org/handle/10665.2/56085 (viewed July 2024).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.